BioCryst Pharmaceuticals | BCRX - Interest Income


BioCryst Pharmaceuticals reported $-0.13 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Chugai Pharma JPY 480M 465M Jun/2024
Daiichi Sankyo JPY 9.96B 230M Mar/2024
DBV Technologies USD -0.32 0.02 Sep/2024
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Novavax USD 303K 27K Dec/2021
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025